|
|
Article: CV THERAPEUTICS RAISES $60M IN PUBLIC OFFERING OF SHARES.
- Article from:
- BIOWORLD Today
- Article date:
- October 8, 1999
- Author:
CopyrightCOPYRIGHT 1999 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
CV Therapeutics Inc. raised $60 million in a publicoffering of 5 million shares that closed Wednesdaynight.
The offering, which priced at $12.00 a share, closedjust a month and a half after the company saw itsstock (NASDAQ:CVTX) soar 56 percent to close at$13.812 a common share following news that a Phase IIIstudy of its lead drug candidate, ranolazine,increased the amount of time patients with severestable angina could spend on a treadmill.
Palo Alto, Calif.-based CV Therapeutics' stock closedThursday at $13.065 a share, down $0.937 a share inheavy trading.
Donaldson, Lufkin & Jenrette Securities Corp., of NewYork; BancBoston Robertson ...